Which companies are involved in this healthcare partnership?

The partnership involves three companies: SMBC Group, Fujitsu Limited, and SoftBank Corp.

What is the main objective of this alliance?

The main objective is to build a domestic healthcare platform to make Japan's healthcare system sustainable by extending healthy life expectancy, improving the operational efficiency of medical institutions, and helping to control national medical expenses.

What will the new healthcare platform consist of?

It will consist of a data platform to securely manage and utilize medical data, and a user application featuring an AI agent that provides personalized health support by combining medical and personal health data with user consent.

What are the roles of each company in this partnership?

SMBC Group will focus on user acquisition and integrating financial services. Fujitsu will lead the development of the data platform and medical AI. SoftBank will lead the development of the user application, leveraging its large user base.

What are the long-term goals of this initiative?

The companies aim to expand the platform's user base to 60 million people, introduce it to 4,000 medical institutions, and contribute to curbing future medical cost increases by an estimated 5 trillion yen.

AI News NQ Analysis

SMBC集团、富士通与软银达成业务合作协议，将建构日本国产健康医疗平台以实现可持续发展的医疗服务

尚無 AI 分析資料。

常見問題

Q: Which companies are involved in this healthcare partnership?: A: The partnership involves three companies: SMBC Group, Fujitsu Limited, and SoftBank Corp.
Q: What is the main objective of this alliance?: A: The main objective is to build a domestic healthcare platform to make Japan's healthcare system sustainable by extending healthy life expectancy, improving the operational efficiency of medical institutions, and helping to control national medical expenses.
Q: What will the new healthcare platform consist of?: A: It will consist of a data platform to securely manage and utilize medical data, and a user application featuring an AI agent that provides personalized health support by combining medical and personal health data with user consent.
Q: What are the roles of each company in this partnership?: A: SMBC Group will focus on user acquisition and integrating financial services. Fujitsu will lead the development of the data platform and medical AI. SoftBank will lead the development of the user application, leveraging its large user base.
Q: What are the long-term goals of this initiative?: A: The companies aim to expand the platform's user base to 60 million people, introduce it to 4,000 medical institutions, and contribute to curbing future medical cost increases by an estimated 5 trillion yen.